Clinical Trials for Lantern Pharma

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Lantern Pharma

Clinical Trials (3)

NCT05933265
Study of LP-184 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
175 participants
Started: Jun 9, 2023 · Completed: Sep 9, 2025
7 conditions1 sponsor9 locations
NCT05456256
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
PHASE2Recruiting
90 participants
Started: Mar 1, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor16 locations
NCT06132503
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
PHASE1Recruiting
110 participants
Started: Jan 3, 2023 · Completed: Nov 30, 2028
2 conditions1 sponsor4 locations